|
Product class:
|
Authorized package
|
|
Medicinal product class:
|
Veterinary medicine
|
|
Package code:
|
1785865
|
|
Name of medicinal product:
|
Animeloxan
|
|
Active substances:
|
|
|
ATC code:
|
QM01AC06
|
|
Dosage form:
|
solution for injection
|
|
Route of administration:
|
subcutaneous use; intramuscular use; intravenous use
|
|
Strengh:
|
20mg 1ml
|
|
Amount in package:
|
100ml 1TK
|
|
Legal status for supply*:
|
Subject to medicinal prescription
|
|
Class of active substance:
|
|
|
Additional information:
|
|
|
Indication:
|
Cattle:
For use in acute respiratory infection with appropriate antibiotic therapy to reduce clinical signs in cattle.
For use in diarrhoea in combination with oral re-hydration therapy to reduce clinical signs in calves of over one week of age and young, non-lactating cattle.
For adjunctive therapy in the treatment of acute mastitis, in combination with antibiotic therapy.
For the relief of post-operative pain following dehorning in calves.
Pigs:
For use in non-infectious locomotor disorders to reduce the symptoms of lameness and inflammation.
For adjunctive therapy in the treatment of puerperal septicaemia and toxaemia (mastitis-metritis-agalactia syndrome) with appropriate antibiotic therapy
Horses:
For use in the alleviation of inflammation and relief of pain in both acute and chronic musculo-skeletal disorders.
For the relief of pain associated with equine colic.
|
|
Safety features:
|
No
|
|
Summary of product characteristics (SPC):
|
 (last updated July 24, 2023)
|
|
Package information leaflet (PIL):
|
EST (last updated July 24, 2023)
|
|
Labelling:
|
(last updated September 24, 2019)
|
|
Withdrawal time:
|
Veis:
Lihale ja söödavatele kudedele: 15 päeva
Piimale: 5 päeva
Siga:
Lihale ja söödavatele kudedele: 8 päeva
Hobune:
Lihale ja söödavatele kudedele: 5 päeva
Ei ole lubatud kasutamiseks hobustel, kelle piima tarvitatakse inimtoiduks.
|
|
Species:
|
veis, siga, hobune
|
|
Last imported to Estonia:
|
February 20, 2023
|
|
Marketing authorization holder:
|
aniMedica GmbH
|
|
Marketing authorization number:
|
2199
|
|
Marketing authorization issued on:
|
September 24, 2019
|
|
Marketing authorization expires on:
|
September 24, 2024
|
|
Marketing authorization procedure type:
|
Mutual recognition
|
Entry/Changing date:
July 24, 2023
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription
You can download Acrobat Reader fromhere